ContributorsPublishersAdvertisers

Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosis

Nature.com
 2021-11-26

Cover picture for the articleThe Mayo-2018 smoldering multiple myeloma (SMM) risk score is used routinely in the clinical setting but has only been validated at diagnosis. In SMM patients, the progression risk decreases over time. However, the utility of applying risk stratification models after diagnosis is unknown. We retrospectively studied 704 SMM patients and applied...

www.nature.com

Comments / 0

Comments / 0